Please use this identifier to cite or link to this item: http://repositorio.unicamp.br/jspui/handle/REPOSIP/79118
Type: Artigo de periódico
Title: Comparative bioavailability of 875 mg amoxicillin tablets in healthy human volunteers
Author: Baglie, S
Rosalen, PL
Franco, LM
Ruenis, APDB
Baglie, RCC
Franco, GCN
Silva, P
Groppo, FC
Abstract: Objective: To compare the bioavailability of amoxicillin 875 mg tablets (EMS Sigma Pharma used as test formulation) and AmoxilO BD 875 mg tablets (GlaxoSmithKline used as reference formulation) in 26 healthy volunteers. Material and methods: 26 healthy volunteers (13 males and 13 females) received each formulation in an open, 2 x 2 crossover, randomized study with seven days of washout period between doses. Plasma samples were obtained over a 12-hour interval after administration. Plasmatic amoxicillin concentrations were obtained by combined reversed-phase liquid chromatography and mass spectrometry with positive ion electrospray ionization using the select ion monitoring method. AUC was calculated by the trapezoidal rule extrapolation method. C-max and t(max) were compiled from the plasmatic concentration-time data. Analysis of variance was carried out using logarithmically transformed AUC(0-inf), AUC(0-12 h), C-max and untransformed t(max). Results: The mean values (+/- SD) for AUC(0-12) (h), (mu g x h x ml(-1)), AUC(0 - 12 h) (mu g x h x ml(-1)), C-max (mu g x ml(-1)), t(1/2) (h) and t(max) (h), were, respectively: 55.42 (+/- 16.85), 55.42 (+/- 16.85), 18.59 (+/- 6.3), 1.49 (+/- 1.57) and 2.04 (+/- 0.75) concerning the test formulation, and 51.11 (+/- 18.9), 51.29 (+/- 19.12), 17.83 (+/- 5.86), 1.52 (+/- 1.31) and 2.02 (+/- 0.87) concerning the reference formulation. Confidence intervals (90%) of amoxicillin means of AUC(0 - 12 h), and C-max ratios (test/reference) were: 0.961 - 1.149 and 0.914 - 1.142 respectively, agreeing with the bioequivalence criteria established by the Brazilian National Health Surveillance Agency. Conclusion: Both formulations were bioequivalent based on both the rate and extent of absorption.
Subject: amoxicillin
comparative bioavailability
bioequivalence
pharmacokinetics
Country: Alemanha
Editor: Dustri-verlag Dr Karl Feistle
Rights: fechado
Date Issue: 2005
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.